Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03593681 · ClinicalTrials.gov registry record
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 150
- Enrollment target
NCT03593681 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 150 participants.
The verdict
NCT03593681 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Prospective, multi-center, non-randomized study to assess the ability of the Cytuity device to collect cell samples from the fallopian tube that can be evaluated for the presence or absence of malignancy.
Interventions
- DEVICE Hysteroscopic cell sampling of the fallopian tube
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2020-02-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03593681
The ClinicalTrials.gov registry entry for NCT03593681 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hysteroscopic cell sampling of the fallopian tube is the first listed.
NCT03593681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03593681 about?
NCT03593681 is a clinical study titled "Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy". Prospective, multi-center, non-randomized study to assess the ability of the Cytuity device to collect cell samples from the fallopian tube that can be evaluated for the presence or absence of malignancy.
What is the current status of trial NCT03593681?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2018-08-27. Estimated completion is 2020-02-14.
What interventions are being tested in trial NCT03593681?
The interventions under investigation include: Hysteroscopic cell sampling of the fallopian tube (DEVICE).
Who is sponsoring clinical trial NCT03593681?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.